Trial Profile
Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Oct 2014
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Sponsors Allergan
- 14 Sep 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 14 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Feb 2009 Additional location identified as reported by ClinicalTrials.gov, last updated 19 Feb 2009